Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer
Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer
About this item
Full title
Author / Creator
Publisher
England: D.A. Spandidos
Journal title
Language
English
Formats
Publication information
Publisher
England: D.A. Spandidos
Subjects
More information
Scope and Contents
Contents
Since nanoparticle albumin-bound (nab)-paclitaxel exerts clinically meaningful antitumor effects on various malignancies, including breast, gastric and non-small-cell lung cancer, we hypothesized that treatment with nab-paclitaxel may also be beneficial for patients with small-cell lung cancer (SCLC). We herein evaluated the safety and efficacy of...
Alternative Titles
Full title
Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4906929
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4906929
Other Identifiers
ISSN
2049-9450
E-ISSN
2049-9469
DOI
10.3892/mco.2016.887
